Johns Hopkins Pathology Homepage Dictionary For Patients For Physicians Giving
Gallbladder and Bile Duct Cancer
Understanding Gallbladder and Bile Duct Cancer Gallbladder and Bile Duct Cancer at Johns Hopkins What's New with Gallbladder and Bile Duct Cancer? Personal Stories Coping with Gallbladder and Bile Duct Cancer Resources for Gallbladder and Bile Duct Cancer


Support Gallbladder and Bile Duct Cancer Research
U.S. News and World Report Rankings Badge


Gallbladder and Bile Duct Cancer

Approximately 7,200 new patients are diagnosed with cancer of the biliary tract (the gallbladder and bile ducts) each year in the United States. This is the second most common type of cancer to involve the region of the liver, following cancer of the hepatocytes (hepatocellular carcinoma).

Each year in the USA, 3600 patients will die of biliary tract cancer, accounting for approximately 1% of all deaths from cancer. Biliary tract cancers are notoriously challenging to diagnose and treat.

The Johns Hopkins Medical Institutions is a leader in the treatment and investigative study of biliary tract cancer. We have created this Web site to give patients and physicians access to the latest clinical and research developments related to this disease, as well as to the multidisciplinary team assembled here to fight biliary tract cancer.








New News!  
March 2013

Hopkins team utilizes whole exome sequencing in biliary cancers.

March 2012

Hopkins team identifies new pathway in Hepatobiliary cancers


 
  
   
Copyright © 2000-2006 The Johns Hopkins University Feedback | Disclaimer